HMX to help University study respiratory health of student population and develop hospital out-patient monitoring strategy.
97.3 percent of the global population breathes unsafe air. Cluster analysis programs are vital to monitoring the effects of global air pollution on the respiratory health of vulnerable populations.”— Louis A. Young II, Founding CEO, Healthmetryx, Inc.
BOSTON, MASSACHUSETTS, USA, July 12, 2022 /EINPresswire.com/ -- Healthmetryx, Inc. (HMX), a health data analytics company, secured a letter of intent (LOI) to conduct two Cluster Analysis Programs (CAP) with The University of Santo Amaro (UNISA) in Sao Paulo, Brazil. The LOI is scheduled for implementation in late 2022. HMX specializes in breath-based, early-detection/self-monitoring technology and anonymized, real-time, respiratory and ambient air-composition data originated from its patent-pending, data-collection device, the Clarinet®.
UNISA seeks to partner with Healthmetryx to execute 2 distinct CAP studies